Deciphering the different phases of preclinical inflammatory bowel disease

JJ Rudbaek, M Agrawal, J Torres… - Nature Reviews …, 2024 - nature.com
Inflammatory bowel disease (IBD) is an immune-mediated inflammatory disease (IMID) of
the gastrointestinal tract and includes two subtypes: Crohn's disease and ulcerative colitis. It …

Inflammation, autoinflammation and autoimmunity in inflammatory bowel diseases

A Padoan, G Musso, N Contran, D Basso - Current issues in molecular …, 2023 - mdpi.com
In this review, the role of innate and adaptive immunity in the pathogenesis of inflammatory
bowel diseases (IBD) is reported. In IBD, an altered innate immunity is often found, with …

Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study

X Xu, L Ai, K Hu, L Liang, M Lv, Y Wang, Y Cui… - Nature …, 2024 - nature.com
Immunotherapy confers little to no benefit in the treatment of microsatellite stable (MSS)
metastatic colorectal cancer (mCRC). Mechanistic insights suggested that epidermal growth …

Integrating multi-omics to unravel host-microbiome interactions in inflammatory bowel disease

Y Zhang, JP Thomas, T Korcsmaros, L Gul - Cell Reports Medicine, 2024 - cell.com
The gut microbiome is crucial for nutrient metabolism, immune regulation, and intestinal
homeostasis with changes in its composition linked to complex diseases like inflammatory …

Prevention of inflammatory bowel disease—The path forward

S Bronze, M Agrawal, JF Colombel… - Alimentary …, 2024 - Wiley Online Library
Background The possibility of preventing inflammatory bowel disease (IBD) is becoming
more plausible due to advances in understanding preclinical disease and successful …

Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms

Y Peng, Y Ma, Z Luo, Y Jiang, Z Xu… - Frontiers in cellular and …, 2023 - frontiersin.org
Objectives Digestive system diseases have evolved into a growing global burden without
sufficient therapeutic measures. Lactobacillus reuteri (L. reuteri) is considered as a new …

A spotlight on intestinal permeability and inflammatory bowel diseases

T Rath, R Atreya, MF Neurath - Expert Review of Gastroenterology …, 2023 - Taylor & Francis
Introduction The intestinal barrier is a multi-faced structure lining the surface of the intestinal
mucosa of the GI tract. To exert its main functions as a physical and immunological defense …

Prediction and prevention of inflammatory bowel disease

EW Lopes, W Turpin, K Croitoru, JF Colombel… - Clinical …, 2024 - Elsevier
11 Acknowledgement: We would like to thank the Helmsley Charitable Trust for their
generous 12 support of the PROMISE consortium (PRediction and PRevention through …

Butyrate: a bridge between intestinal flora and rheumatoid arthritis

Y Cao, J Chen, J Xiao, Y Hong, K Xu, Y Zhu - Frontiers in Immunology, 2024 - frontiersin.org
In patients with rheumatoid arthritis (RA), intestinal flora imbalance and butyrate metabolism
disorders precede clinical arthritis and are associated with the pathogenesis of RA. This …

Analysis of the interferon-γ-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD

E Naschberger, C Flierl, J Huang, L Erkert… - Frontiers in Cell and …, 2023 - frontiersin.org
The development of inflammatory bowel diseases (IBD) involves the breakdown of two
barriers: the epithelial barrier and the gut-vascular barrier (GVB). The destabilization of each …